Guardian Pharmacy Services, Inc.
GRDN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 6.22 | 0.00 | -1.40 | -0.24 |
| FCF Yield | 0.00% | 1.18% | 0.89% | 1.44% |
| EV / EBITDA | 68.92 | 73.61 | 71.91 | 58.34 |
| Quality | ||||
| ROIC | 4.02% | 4.02% | 4.71% | 6.53% |
| Gross Margin | 19.80% | 19.79% | 19.54% | 19.82% |
| Cash Conversion Ratio | – | 2.26 | 1.86 | 1.87 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.52% | 10.77% | 10.64% | 10.56% |
| Free Cash Flow Growth | -100.00% | 33.08% | -34.15% | 344.63% |
| Safety | ||||
| Net Debt / EBITDA | -0.10 | 1.15 | 0.78 | 1.50 |
| Interest Coverage | 102.21 | 73.14 | 76.50 | 39.80 |
| Efficiency | ||||
| Inventory Turnover | 6.32 | 6.25 | 6.10 | 6.69 |
| Cash Conversion Cycle | 3.37 | 4.78 | 6.84 | 5.31 |